LCM
ABBV icon

Legato Capital Management’s AbbVie ABBV Stock Holding History

Legato Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
6,182
+4,296
+228% +$924K 0.13% 239
2026
Q1 		$2.29M Sell
1,886
-6,437
-77% -$1.43M 0.21% 146
2025
Q4 		$1.9M Buy
8,323
+1,515
+22% +$345K 0.16% 193
2025
Q3 		$1.58M Hold
6,808
– – 0.17% 177
2025
Q2 		$1.26M Buy
6,808
+40
+0.6% +$7.43K 0.15% 222
2025
Q1 		$1.42M Hold
6,768
– – 0.19% 169
2024
Q4 		$1.2M Sell
6,768
-7,622
-53% -$1.4M 0.16% 240
2024
Q3 		$2.84M Hold
14,390
– – 0.35% 55
2024
Q2 		$2.47M Buy
14,390
+2,509
+21% +$416K 0.33% 67
2024
Q1 		$2.16M Buy
+11,881
New +$2.05M 0.26% 115

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legato Capital Management's ABBV Position: Q2 2026 in Review

Legato Capital Management increased its AbbVie (ABBV) stake by 228% in Q2 2026, buying an estimated $924K and bringing the position to 6,182 shares worth $1.56M. The position accounts for 0.13% of the portfolio, ranked #239.

Legato Capital Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.84M in Q3 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Legato Capital Management held 6,182 shares of AbbVie worth $1.56M as of Q2 2026.
  • Legato Capital Management bought 4,296 AbbVie shares in Q2 2026, an estimated $924K.
  • AbbVie made up 0.13% of Legato Capital Management's portfolio in Q2 2026, its #239 holding.
  • Legato Capital Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • Legato Capital Management's AbbVie position peaked at $2.84M in Q3 2024.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.